This result indicates that targeting GPER may be an effective means for treating diabetes and obesity, and extends prior work that showed G-1 can ameliorate atherosclerosis in mice (45). This evidence concerns the gene GPER1 and obesity due to melanocortin 4 receptor deficiency.